Frank Waldron-Lynch
0000-0002-0597-4328
2 papers found
Refreshing results…
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes
Missing publications? Search for publications with a matching author name.